PCR For Respiratory Infection Diagnostic Market Analysis 2028

PCR For Respiratory Infection Diagnostic Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Real-Time PCR (qPCR), Multiplex PCR, Traditional PCR, Digital PCR, Reverse-Transcriptase(RT-PCR),and Others), Product Type (Reagents and kits, Instruments, and Others), Infection Type (Virus Infections, Bacteria Infections, and Fungal and other pathogens), and End Users (Hospitals, Physician Clinics, Clinical Laboratories, Academic and Research Institutions, Biotech and Pharma Companies, and Others) and Geography

  • Report Code : TIPRE00023326
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 284
Buy Now

The PCR for respiratory infection diagnostics market was valued at US$ 8279.32 million by 2028 from US$ 4146.02 million in 2021; it is estimated to grow at a CAGR of 10.4% from 2021 to 2028.

Polymerase chain reaction (PCR) is used for accurate point of care diagnostics that help rapidly identify and determine the cause of respiratory tract infections. In addition, PCR is widely preferred in inpatient and outpatient settings that help enhance the growth of the market in recent years.

The growth of the PCR for respiratory infection diagnostics market is attributed to the factors such as the increasing Burden of Chronic Respiratory Diseases (CRDs), growing developments in PCR testing, are widely enhancing the performance of medical devices. However, use of PCR testing for various respiratory infection diagnostics and developments in PCR technology being used to derive them. The availability of alternative assays hinders the market growth.

Lucrative Regions for PCR for respiratory infection diagnostics market

Lucrative Regions for PCR for respiratory infection diagnostics market
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Market Insights

Market Consolidations Strategies Adopted by Use of PCR Testing for Various Respiratory Infection Diagnostics

PCR testing is the gold standard for detecting respiratory infectious diseases, including SARS-CoV-2. Also, the growing developments in PCR are not limited to the COVID-19 testing. The continuous technological developments have allowed researchers to develop advanced PCR techniques at a reduced cost and limit their complexities. It is expected that PCR testing will enhance its capabilities for molecular diagnostics and strengthen its role in the future with the ongoing developments of technologies such as microfluidics and next-generation sequencing. In addition, PCR testing is significantly used in institutions such as nursing homes, chronic care facilities, and hospitals, for identifying influenza virus infection that causes respiratory outbreaks.

Moreover, acute and chronic respiratory infections are among the leading causes of morbidities in the developed and developing countries globally. It is estimated that acute respiratory diseases account for nearly 75% of the total acute morbidities globally. Therefore, various companies are offering various PCR kits that can detect the presence of pathogens that cause respiratory diseases. For instance, companies such as bioMérieux SA and altona Diagnostics GmbH provide a wide range of PCR kits that can detect acute respiratory infection in the upper or lower respiratory tract. Apart from the increasing incidence of acute and chronic respiratory diseases, other factors such as environmental and climatic conditions, air pollution, and discoveries of novel bacteria, viruses, and pathogens are likely to serve as vital growth opportunities for PCR testing for respiratory infection diagnostics in the coming future.

Type -Based Insights

The PCR for respiratory infection diagnostics market, by type, is segmented into real time PCR (qPCR), multiplex PCR, traditional PCR, digital PCR, reverse-transcriptase (RT-PCR), and others. The real-time PCR (qPCR) segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR in the market during the forecast period.

PCR for respiratory infection diagnostics market, by Type – 2021 and 2028

PCR for respiratory infection diagnostics market, by Type – 2021 and 2028
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Product Type-based Insights

Based on product type, the PCR for respiratory infection diagnostics market is segmented into reagents and kits, instruments, and others. The reagents and kits segment held the largest share of the market in 2021 and is anticipated to register the highest CAGR of in the market during the forecast period.

Infection Type-based Insights

Based on infection type, the PCR for respiratory infection diagnostics market is segmented into bacterial infection, viral infection, and fungal and other pathogens. In 2021, viral infections segment held the largest share of the market and is estimated to register the highest CAGR in the market during the forecast period.

End Users-based Insights

Based on end user, the PCR for respiratory infection diagnostics market is segmented into hospitals, physician clinics, clinical laboratories, academic and research institutions, biotech and pharma companies, and others. In 2020, clinical laboratories segment held the largest share of the market and is estimated to register the highest CAGR of in the market during the forecast period.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

PCR For Respiratory Infection Diagnostic Market: Strategic Insights

pcr-for-respiratory-infection-diagnostics-market
Market Size Value inUS$ 4146.02 Million in 2021
Market Size Value byUS$ 8279.32 Million by 2028
Growth rateCAGR of 10.4% from 2021-2028
Forecast Period2021-2028
Base Year2021
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the breast reconstruction market players focus on the collaboration strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name globally.

By Type

  • Real-Time PCR (qPCR)
  • Multiplex PCR
  • Traditional PCR
  • Digital PCR
  • Reverse-Transcriptase (RT-PCR)
  • Others

By Product Type

  • Reagents and Kits
  • Instruments
  • Others

By Infection Type

  • Bacterial Infections
    • Bordetella
    • Streptococcus Pneumoniae
    • Staphylococcus Aureus
    • Haemophilus Influenzae
    • Moraxella Catarrhalis
    • Mycoplasma Pneumoniae
    • Chlamydophila Pneumoniae
    • Legionella
    • Others
  • Viral Infections
    • Rhinoviruses
    • Influenza Virus
    • Severe Acute Respiratory Syndrome (SARS) CoV-2 Virus
    • Respiratory Syncytial Virus (RSV)
    • Adenovirus
    • Enterovirus
    • Parainfluenza
    • Human Metapneumovirus (hMPV)
    • Others
  • Fungal and Other Pathogens

By End User

  • Hospitals
  • Physician Clinics
  • Clinical Laboratories
  • Academic and Research Institutions
  • Biotech and Pharma Companies
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Netherlands
    • Norway
    • Italy
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Middle East and Africa (MEA)
    • Saudi Arabia
    • UAE
    • South Africa
    • Rest of Middle East and Africa
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of South and Central America

Company Profiles

  • Abbott
  • F. Hoffmann-La Roche AG
  • Hologic, Inc.
  • Seegene Inc.
  • AusDiagnostics
  • BD
  • Bio-Rad Laboratories Inc
  • BioMérieux
  • Qiagen
  • Thermo Fisher Scientific Inc
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Type , Product Type , Infection Type , and End Users and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Netherlands, Norway, RoAPAC, RoE, RoMEA, RoSCAM, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


What is PCR test mean?

The polymerase chain reaction (PCR) is a simple and low-cost method for amplifying small portions of DNA. Because significant amounts of a sample of DNA are necessary for molecular and genetic analyze, studies of isolated fragments of DNA are almost impossible without PCR amplification.

What are the driving factors for the PCR for respiratory infection diagnostics market across the globe?

The growth of the market is attributed to some key driving factors such as as the increasing Burden of Chronic Respiratory Diseases (CRDs), growing developments in PCR testing, are widely enhancing the performance of medical devices. However, use of PCR testing for various respiratory infection diagnostics and developments in PCR technology being used to derive them. The availability of alternative assays hinders the market growth. In January 2020, Roche received CE Mark approval for an adenovirus test for transplant patients. It is intended to be used in conjunction with other infectious diseases tests available on their cobas systems (6800 and 8800). The majority of companies are now offering real-time polymerase chain reaction (PCR) tests for corona virus, which is contributing to the growth of the target market.Such strategic steps are also projected to drive the market growth.

What is the regional analysis in terms of PCR for respiratory infection diagnostics?

The growth of the region is attributed to factors such as rising public–private partnerships, and increasing funding activities are widely enhancing the performance of medical devices. Moreover, presence of well-developed healthcare infrastructure and government support are some of the prominent factors propelling the market growth in Asia Pacific. In addition, the Europe is expected account for the fastest growth in the PCR for respiratory infection diagnostics market. A high demand in research, growing support from governments, continuously changing disease profiles, rising public–private partnerships, and increasing funding activities are widely enhancing the performance of medical devices growth of Europe PCR for respiratory infection diagnostics market during the forecast period.

The List of Companies - PCR for Respiratory Infection Diagnostic Market

  1. Abbott
  2. F. Hoffmann-La Roche AG
  3. Hologic, Inc.
  4. Seegene Inc.
  5. AusDiagnostics
  6. BD
  7. Bio-Rad Laboratories Inc
  8. BioMérieux
  9. Qiagen
  10. Thermo Fisher Scientific Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to PCR For Respiratory Infection Diagnostic Market